KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Account Payables (2021 - 2025)

LifeMD filings provide 5 years of Change in Account Payables readings, the most recent being -$300768.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 50.41% to -$300768.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 22.31% decrease, with the full-year FY2025 number at $3.2 million, down 22.31% from a year prior.
  • Change in Account Payables hit -$300768.0 in Q4 2025 for LifeMD, up from -$4.7 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8.6 million in Q2 2025 to a low of -$4.7 million in Q3 2025.
  • Median Change in Account Payables over the past 5 years was $124633.0 (2021), compared with a mean of $447307.2.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 1887.81% in 2022 and later tumbled 680.84% in 2025.
  • LifeMD's Change in Account Payables stood at -$2.4 million in 2021, then surged by 76.07% to -$576066.0 in 2022, then soared by 351.27% to $1.4 million in 2023, then tumbled by 141.9% to -$606501.0 in 2024, then skyrocketed by 50.41% to -$300768.0 in 2025.
  • The last three reported values for Change in Account Payables were -$300768.0 (Q4 2025), -$4.7 million (Q3 2025), and $8.6 million (Q2 2025) per Business Quant data.